Delivery Order SPE2DB20D3505-SPE2DB25FYCDH
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Jardiance 10 mg tablets in a 90-count package. This delivery order, valued at $26,553.55, represents a firm fixed-price contract with no set-aside designation, reflecting a competitively awarded procurement. The contract is scheduled for completion by September 4, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $13,387.05 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on September 2, 2025, with an ultimate completion date of September 3, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Jardiance is a prescription medication used in diabetes management, representing one...
- The Defense Logistics Agency awarded a delivery order valued at $15,735.96 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units) on September 3, 2025, with an ultimate completion date of September 4, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Jardiance is a prescription diabetes medication commonly used by...
- The Defense Logistics Agency awarded a delivery order valued at $8,440.75 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count) on August 28, 2025, with completion scheduled for August 29, 2025. This firm fixed price delivery order represents a non-set-aside competitive award and will be performed at the vendor's corporate office in Conshohocken, Pennsylvania. Jardiance is a diabetes medication commonly used by military personnel and veterans through the Defense...
- The Defense Logistics Agency awarded a delivery order valued at $11,632.89 to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Jardiance 10 mg tablets (90-count packages). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of July 23, 2025, with performance at the vendor's facility in Conshohocken, Pennsylvania. Jardiance is a diabetes medication commonly prescribed for type 2 diabetes management, reflecting the critical pharmaceutical supply needs...
- The Defense Logistics Agency awarded a delivery order valued at $106,071.13 to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Jardiance 25 mg tablets (90-count units). This firm fixed-price, non-set-aside contract is scheduled for completion by September 5, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. Jardiance is a diabetes medication commonly used in military and federal healthcare systems, reflecting the...
- The Defense Logistics Agency awarded a delivery order valued at $6,496.48 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count packages) on August 1, 2025, with an ultimate completion date of August 4, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Jardiance is a diabetes medication commonly used within military and...
- The Defense Logistics Agency awarded a delivery order valued at $7,793.38 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count packages) on August 28, 2025, with completion expected by August 29, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania. Jardiance is a diabetes medication commonly used within military...
- The Defense Logistics Agency awarded a delivery order valued at $12,196.14 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count packages) on August 8, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Jardiance is a prescription medication used in diabetes management, representing...
- The Defense Logistics Agency awarded a delivery order valued at $5,240.80 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count) on July 22, 2025, with an ultimate completion date of July 23, 2025. This firm fixed price delivery order represents a non-competitive procurement and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Jardiance is a diabetes medication commonly used in military and federal healthcare systems to...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB25FYCDHDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $7,229.91 to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Jardiance 10 mg tablets (90-count units). This non-set-aside, competitively awarded contract represents a firm fixed-price delivery order with a completion date of September 4, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Jardiance is a prescription diabetes medication commonly used within military and federal healthcare systems to support chronic disease management for beneficiaries. This delivery order operates under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that enables the contractor to supply comprehensive pharmaceutical products and medical commodities to support military healthcare programs globally. AmerisourceBergen's established role as a major pharmaceutical distributor and critical federal medical procurement vendor, combined with its demonstrated capability to fulfill open competition awards across diverse therapeutic domains, positions it as a primary supplier for the Defense Health Agency and other federal healthcare systems. The relatively short contract performance window reflects the urgent nature of pharmaceutical resupply requirements within federal medical supply chains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.2k | 9/3/25 |